Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 8/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.81 |
| ▸ | SLC10A2 | Q12908 | 2/20 | 0.81 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.81 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.81 |
| ▸ | VDR | P11473 | 1/20 | 0.80 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.80 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.77 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | CA1 | P00915 | 5/20 | 0.68 |
| ▸ | CA2 | P00918 | 5/20 | 0.68 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycodeoxycholate SCHEMBL27652429 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL13851639 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL26088647 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL24841 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL23704979 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL1218231 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL23704978 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL23710381 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL20955852 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A | |
| Glycodeoxycholate SCHEMBL24840 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2TBXA2RPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 37671 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746917-A1 | VACCINE | GlaxoSmithKline Biologicals SA (BE) | 2026-05-27 | — | — | EP | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260139329-A1 | METHOD TO CHARACTERIZE NUCLEIC ACID | ICHORtec GmbH (DE) | 2026-05-21 | — | — | US | claimed |
| US-20260131089-A1 | DRUG DELIVERY DEVICES AND METHODS FOR ADMINISTERING SUBSTANCES TO A BODY CAVITY BY HETEROGENOUS AEROSOLIZATION FOR TREATMENT OF BINGE-EATING DISORDERS AND/OR OBESITY | APTARGROUP, INC. (US) | 2026-05-14 | — | — | US | claimed |
| CN-122012182-A | Method for synthesizing branched fatty acid ester of hydroxy fatty acid by taking natural oil containing hydroxy fatty acid as raw material | 江南大学 | 2026-05-12 | — | — | CN | claimed |
| WO-2026085618-A1 | METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION | YYZ PHARMATECH INC. (CA) | 2026-04-30 | — | — | WO | claimed |
| EP-4727564-A2 | COMPOSITIONS AND METHODS FOR MICROBIOME DYSBIOSIS | The University of Chicago (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4724839-A2 | CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING SLOW RELEASE OF GLAUCOMA TREATING DRUGS AND COMFORT ENHANCING DRUGS | Mediprint Ophthalmics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260097044-A1 | ION PAIR LIQUID CRYSTAL FORMULATIONS FOR LONG-ACTING INJECTABLES OF POORLY SOLUBLE DRUGS | FORDOZ PHARMA CORP. (US) | 2026-04-09 | — | — | US | claimed |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | APTARGROUP, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-4649120-A | PROLINE, SODIUM DEOXYCHOLATE | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1987-03-10 | — | — | US | claimed |
| EP-0211029-A1 | IMPROVEMENTS RELATING TO INFLUENZA VACCINE | MEDICAL RESEARCH COUNCIL (GB) | 1987-02-25 | — | — | EP | claimed |
| WO-1986004242-A1 | IMPROVEMENTS RELATING TO INFLUENZA VACCINE | MEDICAL RESEARCH COUNCIL (GB) | 1986-07-31 | — | — | WO | claimed |
| EP-0188450-A1 | METHODS FOR THE IN VITRO DETECTION AND IDENTIFICATION OF UNKNOWN PATHOGENS OR GENETIC ENTITIES. | DIAGNOSTIC RESEARCH LIMITED PA (US) | 1986-07-30 | — | — | EP | claimed |
| WO-1986000139-A1 | METHODS FOR THE IN VITRO DETECTION AND IDENTIFICATION OF UNKNOWN PATHOGENS OR GENETIC ENTITIES | DIAGNOSTIC RESEARCH LIMITED PARTNERSHIP (US) | 1986-01-03 | — | — | WO | claimed |
| US-4497899-A | THROUGH CELL LYSIS | ABBOTT LABORATORIES (US) | 1985-02-05 | — | — | US | claimed |
| US-4497900-A | THROUGH CELL LYSIS AND SOLID PHASE ADSORPTION | ABBOTT LABORATORIES (US) | 1985-02-05 | — | — | US | claimed |
| US-4454232-A | IMMONASSAY, SURFACTANTS | BIO-RAD LABORATORIES, INC. (US) | 1984-06-12 | — | — | US | claimed |
| US-4271147-A | Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1981-06-02 | — | — | US | claimed |
| US-4022667-A | Substrate solution for carboxylic ester hydrolase determination | THE UNIVERSITY OF ALABAMA (US) | 1977-05-10 | — | — | US | claimed |